Industry vets David LeCause, Darryl Lemecha join board at spring meeting.

Prevent Blindness, a volunteer eye health and safety organization, has announced that David P. LeCause, vice president of U.S. Eye Care for Allergan Inc., and Darryl Lemecha, executive vice president and chief technology officer of VSP Global, have been elected to the organization’s board of directors. The vote was held on March 5 at the board’s 2016 spring meeting in St. Petersburg, FL.

LeCause has more than 25 years of experience in the industry. Prior to leading Allergan’s U.S. eyecare commercial business unit, he served as vice president of U.S. eyecare sales and as region director of U.S Therapeutics in the eyecare division of Allergan.

As executive vice president and chief technology officer of VSP Global, Lemecha is responsible for increasing efficiencies in the company’s lines of business with the goal of enhancing the customer experience. Preceding his role with VSP Global, Lemecha served as COO of Eyefinity, a subsidiary of VSP Global where he directed product management, product engineering, business intelligence and customer care organizations.


David LeCause (left), Darryl Lemecha (right)

 
SPONSORED VIDEO: OPTOMETRY WORTH SHARING

HOW TO AVOID AUDIT HELL

You may think you’re ready for a Medicare Audit. But are you? Little things count—but they can mean the difference between a great outcome and one that leaves you out in the cold. Don’t get swallowed up by the audit machine. Get this free guide to preparing for — and surviving — a Medicare Audit. Simply fill out the form to the right to access the information. Because you can survive “Audit Hell” if you’re prepared. Download Audit Kit ➡

Promoted Headlines